Latest news
Loading news…
NellOne Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Knoxville, Tennessee, United States Founded 2007 1-10 employees For Profit
NellOne Therapeutics develops Nell1 protein therapeutics for restoring tissue mass and function in patients recovering from heart attacks.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 34
- Active products
- 9
- IT spend
- $24K
Company Info
- Founded
- 2007
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 1
- HQ
- Knoxville, Tennessee, United States
- Region
- Southern US
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 1.6
- Trend (90d)
- 1.3
Key People at NellOne Therapeutics
Acting CEO
Chief Executive Officer
3
professional contacts at NellOne Therapeutics
Contact execs at NellOne Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to NellOne Therapeutics
Loading news…
FAQs about NellOne Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.